Limited Therapeutic Effect of N‐Acetylcysteine on Hepatic Insulin Resistance in an Experimental Model of Alcohol‐Induced Steatohepatitis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Alcohol‐related steatohepatitis is associated with increased oxidative stress, DNA damage, lipotoxicity, and insulin resistance in liver. As inflammation and oxidative stress can promote insulin resistance, effective treatment with antioxidants, for example, N‐acetylcysteine (NAC), may restore ethanol‐impaired insulin signaling in the liver. Methods: Adult male Sprague–Dawley rats were fed for 130 days with liquid diets containing 0 or 37% ethanol by caloric content, and simultaneously treated with vehicle or NAC. Chow‐fed controls were studied in parallel. Liver tissues were used for histopathology, cytokine activation, and insulin/IGF‐1 signaling assays. Results: We observed significant positive trends of increasing severity of steatohepatitis (p = 0.016) with accumulation of neutral lipid (p = 0.0002) and triglycerides (p = 0.0004) from chow to control, to the ethanol diet, irrespective of NAC treatment. In ethanol‐fed rats, NAC reduced inflammation, converted the steatosis from a predominantly microvesicular to a mainly macrovesicular histological pattern, reduced pro‐inflammatory cytokine gene expression, ceramide load, and acid sphingomyelinase activity, and increased expression of IGF‐1 receptor and IGF‐2 in liver. However, NAC did not abrogate ethanol‐mediated impairments in signaling through insulin/IGF‐1 receptors, IRS‐1, Akt, GSK‐3β, or p70S6K, nor did it significantly reduce pro‐ceramide or GM3 ganglioside gene expression in liver. Conclusions: Antioxidant treatments reduce the severity of chronic alcohol‐related steatohepatitis, possibly because of the decreased expression of inflammatory mediators and ceramide accumulation, but they do not restore insulin/IGF‐1 signaling in liver, most likely due to persistent elevation of GM3 synthase expression. Effective treatment of alcohol‐related steatohepatitis most likely requires dual targeting of oxidative stress and insulin/IGF resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“However, contrary to findings in other models (Cai et al., 2005; McClain et al., 1999; Ronis et al., 2008; Wang et al., 2009), we did not observed a significant role for NAC inhibition of pro-inflammatory cytokines in relation to the reduced severity of alcohol-related steatohepatitis.”
ResultN-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · cited 3×
“…levels in ALD and non-alcoholic liver disease are reduced (Das et al., 2008; Videla et al., 2004), we investigated the therapeutic effects of NAC, an anti-oxidant that promotes glutathione synthesis (Aruoma et al., 1989; Atkuri et al., 2007), on the severity of alcohol-induced steatohepatitis.”
BackgroundChavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · cited 2×
“…ceramides are key mediators of lipotoxicity with attendant increased inflammation, oxidative stress, and insulin resistance in both ALD and nonalcoholic fatty liver disease (Chavez et al., 2003; Fernandez-Checa et al., 2005; Holland et al., 2007; Pickersgill et al., 2007; Schutze et al., 1992).”
BackgroundEnhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355 · cited 9×
“The studies demonstrated similar mean levels of TNF-α, IL-4, IL-6, and VEGF among the five study groups (Table 4; Figure 4).”
BackgroundInfluentialKabayama, K. (2004) · Glycobiology · doi:10.1093/glycob/cwh135 · Cited by 155 · cited 2×
“Insulin-resistance induced by TNF-α was shown to be associated with increased GM3 and reduced insulin receptor accumulation in detergent-resistant membrane microdomains, together with uncoupling of insulin receptor-IRS-1 signaling (Kabayama et al., 2005; Kabayama et al., 2007), Correspondingly, chemical inhibition of…”
BackgroundLimited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus
Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151 · cited 1×
“Relative mRNA abundance was calculated from the ng ratios of specific mRNA to 18S measured in the same samples (Moroz et al., 2008).”
Method
Cited by
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 342
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
De Andrade, K., Moura, F., Dos Santos, J., De Araújo, O., De Farias Santos, J., & Goulart, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226225 · Cited by 253
Ballway, J. W., & Song, B.-J. (2021) · Antioxidants · doi:10.3390/antiox10030384 · Cited by 72
Shearn, C. T., Smathers, R. L., Backos, D. S., Reigan, P., Orlicky, D. J., & Petersen, D. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.011 · Cited by 69
“The PTEN/Akt pathway contributes to regulation of metabolic pathways in the liver and has previously been implicated in the formation of chronic ethanol mediated steatosis [30, 31].”
BackgroundSelf-citationShearn, C. T., Backos, D. S., Orlicky, D. J., Smathers-McCullough, R. L., & Petersen, D. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543942 · Cited by 57
Self-citation
Metadata
- Authors
- Setshedi, M., Longato, L., Petersen, D. R., Ronis, M., Chen, W. C., Wands, J. R., & de la Monte, S. M.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2011-07-25
- Volume
- 35
- Issue
- 12
- Pages
- 2139-2151
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W2165013512
- Cited by
- 48
- References
- 7
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Limited Therapeutic Effect of N‐Acetylcysteine on Hepatic Insulin Resistance in an Experimental Model of Alcohol‐Induced Steatohepatitis. https://app.cochat.ai/papers/10.1111/j.1530-0277.2011.01569.x
- The paper
- Setshedi, M., Longato, L., Petersen, D. R., Ronis, M., Chen, W. C., Wands, J. R., & de la Monte, S. M. (2011). Limited Therapeutic Effect of N‐Acetylcysteine on Hepatic Insulin Resistance in an Experimental Model of Alcohol‐Induced Steatohepatitis. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.2011.01569.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.